Q1 2022 Acadia Healthcare Company Inc Earnings Call

Good morning, and welcome to Acadia Healthcare's first quarter 2022 earnings call all participants will be in listen only mode.

Should you need assistance. Please signal a conference specialist by pressing the star key followed by zero.

After today's presentation there'll be an opportunity to ask questions to ask a question you May Press Star then one on your telephone keypad to withdraw your question. Please press Star then two please note. This event is being recorded I would now like to turn the conference over to Gretchen Homrich. Please go ahead.

Good morning, and welcome to Acadia <unk> first quarter 2022 conference call I'm, Gretchen Homrich, Vice President of Investor Relations for Acadia I'll first provide you with our safe Harbor before turning the call over to our Chief Executive Officer, Chris Hunter.

To the extent any non-GAAP financial measure is discussed in today's call. You'll also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under the investors link.

This conference call may contain forward looking statements within the meaning of the private Securities Litigation Reform Act of 1995, including statements among others regarding <unk> expected quarterly and annual financial performance for 2022 and beyond.

For this purpose any statements made during this call that are not statements of historical fact may be deemed to be forward looking statements without limiting the foregoing. The words believes anticipates plans expects and similar expressions are intended to identify forward looking statements.

You are hereby cautioned that these statements may be affected by the important factors among others set forth in Acadians filings with the Securities and Exchange Commission and in the company's first quarter news release, and consequently, actual operations and results may differ materially from the results discussed in the forward looking statements.

The company undertakes no obligation to update publicly any forward looking statements, whether as a result of new information future events or otherwise.

At this time for opening remarks, I would like to turn the conference call over to Chief Executive Officer, Chris Hunter.

Thank you Gretchen good morning, everyone and thank you for being with US today for our first quarter 2022 conference call I'm here today, with Chief Financial Officer, David Duckworth and other members of our executive management team.

David and I will provide some remarks about our business and financial and operating results for the first quarter of 2022. Following our comments, we will open the line for your questions.

But before we get into the results I just want to start by saying what an honor. It is to be with you today as the new CEO Acadia is a strong respected organization and I look forward to building on the successful trajectory set by Debbie O'steen and the Acadia leadership team I want to personally thank Debbie for her leader.

Ship for the solid foundation should leaves in place for her time since I joined the company and for the future work ahead as we continue our CEO transition plan.

I am grateful that Debbie is continuing her role on our board of directors and no we will benefit from her expertise.

Some quick background on me I am passionate about health care and the difference our industry makes in People's lives.

Work in the healthcare industry now for over two decades in managed care and health care it.

For the past eight years I've worked at Humana and two different roles first is humana's Chief strategy officer with responsibility for corporate strategy and mergers and acquisitions and most recently as the president of a business unit that together serve the combined 20 million members in 45 states.

Prior to Humana I ran the provider business. It drives Edo Corporation and from these multiple vantage points I have witnessed firsthand the critical need for effective behavioral health solutions.

As we may finally be emerging from the height of the COVID-19 pandemic. There is clear evidence that the challenges around mental health are only increasing recent studies reported that approximately one third of Americans experienced elevated depressive symptoms in 2021 compared to only eight.

5% prior to the pandemic, while more than 55% of adults with mental illness received new treatment for their condition as.

As the leading pure play provider of behavioral health care services Acadia has a significant opportunity to meet this critical societal need in our country.

We take this responsibility seriously and across our operations, we have a shared commitment to ensure that Acadia is well positioned to address this growing need.

Since I joined three weeks ago, I have been encouraged by our team's discipline and ability to execute in a tough environment with COVID-19 and labor challenges, while continuing to meet the growing demand across all of our service lines. I'm also very impressed with our diversified offering of comp.

Hence of services within behavioral health, which are focused on real patient needs that continued to be under treated and the strong growth pathways across our businesses to serve those patients.

Moving to an update on the first quarter, we continued to build on our solid foundation and proven operating model through Acadia for strategic growth pathways.

First our facility expansion efforts continue to address the unmet demand for behavioral health care services and reach more patients in new and existing markets. We added 28 beds to current facilities in the first quarter and expect to add approximately 300 beds through.

Through facility expansion this calendar year.

Our second growth Avenue is to identify underserved markets for behavioral health treatment and develop wholly owned de novo facilities that helped build this gap.

At the end of 2021, Acadia completed the purchase of three non operational facilities in Chicago.

We have since commence work on the plant improvements for a 60 bed children's hospital that we expect to open next month.

In addition, both a 101 bed adult hospital in an outpatient facility are slated to begin Chicago operations in 2023 and will operate as monstrous behavioral health Hospital.

Additionally, we continue to expand our network of comprehensive treatment centers or <unk>, which are designed to address the growing and critical need for medication assisted treatment for patients dealing with opioid use disorder.

In the first quarter of 2022, we opened one new CTC in Virginia, and we plan to open at least five more ctc's in 2022.

Our third lever for Acadia as continued growth is through joint venture partnerships, we announced six new partnerships with health systems in 2021 and plan to open a new facility in partnership with Covenant Health in Knoxville, Tennessee. This summer and expect to launch operations in our new facility in partnership with the <unk>.

<unk> Health network in Fort Wayne, Indiana later in 2022.

Working together with these partners, we can combine our expertise and resources with a shared commitment to expand access to quality behavioral healthcare.

Finally for our fourth growth pathway, we will continue to look for acquisition opportunities in high growth markets that meet the criteria of our disciplined capital allocation framework.

<unk> has a proven operating model and our strategy is to identify facilities and programs, where we can leverage our scale and expertise make necessary investments for expansion and add service offerings to further enhance the continuum of care.

So to recap these four growth avenues in 2022, we expect to add over 600 beds in total through approximately 300 bed additions to existing facilities opening two inpatient de novo's two facilities with JV partners and at least six CTC locations.

As we witness the significant need for more effective treatment. We have also seen a greater public acceptance of mental health parity of mental health at parity with other health issues as well as a reduction in the stigma that is often prevented patients from seeking the help they need.

My goal is to build upon our strong momentum and extend our market reach to more patients and communities. We will continue to execute on our strategic growth plans as we address the unmet needs that exist across all service lines.

I plan to conduct ongoing reviews of each of our businesses in order to identify incremental opportunities to create long term value and determine how we can best position Acadia to lead the industry into the future.

I look forward to sharing this perspective in the coming months and also to conducting our first Acadia Investor Day in New York later this year.

I would like to address some of our industry headwinds.

As with many other health care providers and other industries across the country. We are currently dealing with a tight labor market.

At the same time I've been impressed with our team's ability to manage through this environment with an unwavering focus on treating our patients we continue to be intentional in recruiting and retaining our clinical staff in line with patient needs and we believe we have the tools to effectively manage through potential challenge.

As we continue to be successful with recruiting new employees through robust local efforts and utilizing our centralized recruiting function to support our facilities.

While we are focused on market competitive pay for our valuable employees, our wage inflation is manageable and our premium pay is stable and continues to account for a low percentage of our labor cost.

As always our primary mission is to support the patients and communities. We serve we will continue to focus on providing high quality patient care, while extending our market reach and advancing our position as a leading behavioral health care provider that our country is counting on to grow.

And serve more families in need.

At this time I will now turn the call over to David Duckworth to discuss our financial results for the quarter and our 'twenty to 2022 guidance in more detail.

Thanks, Chris and good morning.

Looking at the first quarter, we delivered a solid financial and operating performance, marking a strong start to 2020 to Huawei.

While we faced some early challenges in January related to the surge of the omicron Varian of COVID-19, our operating trends recovered quickly with meaningful improvement in February and March.

Our facilities have managed well through each stage of the pandemic with strict protocols in place to ensure high standards of safety for our patients with minimal disruptions to our operations.

We successfully delivered on our key performance metrics in the first quarter, demonstrating consistent execution of our strategy.

Revenue for the first quarter increased 11, 9% to $616 $7 million compared with $551 2 million for the first quarter of 2021.

<unk> adjusted EBITDA for the first quarter of 2022 was 100 $135 5 million.

Paired with $119 5 million for the same period last year and.

And adjusted EBITDA margin was 22%.

Compared with 21, 7% in the prior year.

Adjusted income attributable to Acadia stockholders per diluted share was <unk> 67.

For the current period presented in our earnings release adjusted income excludes transaction related expenses and income tax effects.

For the first quarter of 2022, our same facility revenue increased eight 6% compared with the first quarter of 2021, including an increase in revenue per patient day of six 2% and an increase in patient days of two 2%.

We have experienced robust demand for our behavioral health care services, and our dedicated team of employees and clinicians across our operations have continued to support our patients with high quality patient care.

Our balance sheet remains strong with ample liquidity flexibility and capital to support our growth strategy and future investments.

As of March 31st Acadia had a $144 million in cash and cash equivalent.

And $440 million available under our $600 million revolving credit facility.

Our net leverage ratio at the end of the quarter was approximately two three times.

During the first quarter. The company continued its repayment of amounts received pursuant to the Medicare accelerated and advanced payment program under the cares Act.

The $45 million of advanced payments received in 2020, the company repaid $25 million in 2021 and made additional payments of $8 million in the first quarter of 2022.

We will continue to repay the remaining balance throughout 2022.

We will also repay the remaining half of the approximately $39 million of 2020 payroll tax deferrals in the second half of 2022.

Now turning to our guidance as noted in our press release, we are affirming our previously stated guidance for 2022, which includes revenue in a range of two 505 to $2 6 billion.

Adjusted EBITDA in a range of 575 million to $610 million.

And adjusted earnings per diluted share in a range of $2 85 to.

To $3 15.

As a reminder, this guidance does not include the impact of any future acquisitions divestitures or transaction related expenses.

With that Joe we are ready to open the call for questions.

We will now begin the question and answer session to ask a question you May Press Star then one on your Touchtone phone.

Youre using a speakerphone please pick up your handset before pressing the keys.

If at any time. Your question has been addressed and you would like to withdraw. Your question. Please press Star then two please limit yourself to one question and one follow up at this time, we will pause momentarily to assemble the roster.

Our first question will come from Brian <unk> from Jefferies. Please go ahead.

Hey, good morning, guys, Chris welcome to the <unk>.

Paul Nice to meet you here I guess my first question for you.

Obviously, new to the job, but I'm sure you've done a lot of diligence on the company before you.

Took this position so just curious how you are seeing.

How youre thinking about the strategy I know you laid out the growth.

The goals earlier, but as you look at Acadia anything you can see where.

You can enhance the strategy or where there are opportunities to improve and then I guess, maybe conversations with the board in terms of your mandate as CEO as you step into the role.

Yeah, no. Thank you Brian I really appreciate the question a.

A few things that I'd start with from the outset.

I really like the diversification across all areas of behavioral health from those with psychiatric needs to substance use disorder and co occurring disorders.

Even serving patients of all ages, we have diversification across all lines of business payer mix geography, and as I've started into the role I'm, particularly impressed with the strong execution of the team I think particularly as we discussed in the prepared remarks during a very difficult stretch with industry <unk>.

Winds around Covid and the tight labor market.

But I think with a strong balance sheet the levers of growth that we discussed earlier.

There is a lot that excites me around our future prospects.

I would say that I would like to see the behavioral sector overall, probably embraced technology.

In Digitization and take advantage of cost benefits and efficiencies and even revenue enhancements and.

In other ways to just further enhance our platform, but it is really building off a base of foundational strength and I think we just have we will continue to have significant opportunity ahead of us in terms of the board mandate.

I am in week, three and haven't had my first board meeting, yet, but I'm very excited and have spoken to the board about the ability to grow the company. The strategic levers that we currently have in front of us and just how positioned we are with real tailwind from a demand standpoint across all four of our lines of business.

I appreciate that and then David just my follow up question Rev per patient day was pretty strong is there anything to call out. There then how do you think about the sustainability of that level of growth in that metric.

Okay.

We have seen a strong revenue per day performance, which we saw throughout 2021 and continued into the first quarter and.

We would say that the most significant component of that is rate increases that we're seeing.

Broadly across many of our payers and many of our service lines.

We have a team that maintains.

Close and collaborative relationship with our commercial and our other managed care payers.

And <unk> have worked with them very well at a local level and at a corporate level on those rate increases.

Payer mix for the company is part of our strong revenue per day this quarter.

We saw our commercial volumes at just over 30%.

But most of that $6 two increase that we saw on a same facility basis is rate increases that we are getting from our payors.

Awesome. Thank you.

Our next question comes from Whit Mayo with SBB Leerink. Please go ahead.

Hey, thanks.

Maybe for David.

Given the increased level of activity that you have on the development front all these joint ventures all of you.

New construction.

Projects are there any.

Changes in strategy talent processes, just anything or as you refine the resources around.

Around the construction side it just feels like there should be some opportunities to drive enhanced scale across some of these construction cost with all this activity.

Yes.

We are of course planning for a significant amount of growth embedded issuance over the next several years.

We continually focus on the resources that we need to execute on the plan. We have a strong team already but we will continue to look at the right team as we bring new facilities online. Many of those are joint venture relationships, where we've already built strong.

<unk> shifts with those partners for those facilities that we have planned. So we will continue to look at resources that we need as we've always done from a construction perspective.

We have added resources to our construction department over the last year and are.

Are looking at a number of initiatives.

Many of those are too.

Open the beds as quickly as we can where can we shorten certain parts of the process for opening and building those beds.

But many of them are also focused on the cost and the efficiencies that we might be able to find within construction. So we stay focused on our growth we want to open all of these beds as quickly and as efficiently as we can and we have built the team and we'll continue to build the team around those.

Those initiatives.

That's helpful and just maybe one follow up on just the CTC business and I guess I mean this in the context of sort of labor, we get a lot of questions around maybe how that labor or the staff model has evolved in the pandemic and maybe if you could just talk about some of the trends in that business as you sort of compare and contrast, it to acute.

Psycho residential treatment. Thanks.

Yes.

That business has grown and we've opened new clinics and continue to see a strong performance from our CTC service line and reimbursement has improved as many states have added Medicaid coverage and have been focused at a state level on on more treatment options and more low.

Occasions for the opiate use treatment and so we have grown along with that.

And continue to look for opportunities to open new locations and grow the ones that we already have from a staffing perspective. The model does look different for our CTC compared to our other service lines.

The.

Nursing is a significant component of that service line.

At around a third of our clinical employees, but we do have a higher utilization there of Lps relative to the acute business that would have more rns.

And then and then the other significant category would just be counselors and therapists and we remain focused on recruiting and retaining the that counselors and therapists within that service line.

But the staffing model there does have a much higher mix of both the counters and therapist and a greater ability to utilize LPN versus our other service lines.

Great. Thanks, a lot.

Thanks Whit.

Our next question comes from Kevin Fischbeck with Bank of America. Please go ahead.

Great. Thanks.

Maybe Chris just wanted to go back to your.

Your comments in your prepared remarks, you talked about.

Kind of doing ongoing business reviews, and driving incremental value I think.

I was wondering what the new CEO might bring with them.

Sounds to me like Youre basically.

We validating the four pillars of growth in kind of the long term growth outlook of the company, but you see additional opportunity for upside am I interpreting that correctly or is there. Some other nuance we should be taking away from.

This kind of business review process youre going through it.

Yes, no. Thank you for the question, Kevin I would start just by saying that.

The company has four very strong levers of growth between the facility expansions the de novo's, the Jv's and obviously M&A.

And we will continue to want to build upon this really strong core foundation that we have I do think that there will be some opportunities I will see them as enhancements along the way and we will certainly look at partnerships and we will look at things that we can do to continue to.

Accelerated growth, but I, just want to reinforce and had an opportunity to spend some time with our top operators last week that we really need to continue to execute on doing a great job to produce the strong quarter that we have the privilege of talking about right now and we will be looking for every opportunity.

To continue to enhance that as we go and clearly we will be drawing on.

My background in.

Really look forward to trying to bring some innovation to the business, where it makes sense, but in a prudent way and over a period of time.

Okay. That's helpful. And then just on labor cost, which is obviously a big focus some of your peers have struggled even broadly speaking a number of companies. This quarter have struggled with labor cost I guess, what would you attribute.

Overall your ability to manage through this because is it.

The rate updates that you've been getting that kind of give you a little bit more.

Cover to raise wages or is there something else you would point because I wouldn't think about behavioral necessarily as being an easy place to recruit into generally speaking so when labor is a little bit tight.

It's pretty impressive what you've done.

Additional color there would be helpful. Thanks.

Yes, Kevin.

We have been navigating in our view are tight.

Tight labor market overall for the last several quarters and the team continues to do.

A fantastic job navigating the market. We are in 40 states plus Puerto Rico, and we continue to believe that each market has a different challenge and not all markets do see a challenge and it is helpful that we have different service lines and different types of employees within each.

Service line that's.

That's not to say that we don't have challenges across the different categories and across our markets.

But it does look different from one market and one job caddick category to another and I would just have to give credit to our facility leadership teams and our recruiting team.

At the facility, but also supported by centralized recruiting resources that we have at the corporate level.

We keep a proactive approach to staffing.

We are always planning.

To have staff available so it does not impact our volume.

We want to make sure that if it staffing does impact our volume, it's only temporary and we bring the right resources.

To fix the situation and continue to support.

The strong inquiries and demand that we're seeing across our service lines and markets and so to US. It's all about just the proactive approach having the tools in place having the focus.

On on managing the staff recruiting using premium pay if we need to.

All of that has made it manageable.

You mentioned rates, we have seen improvement year over year, and our salaries and wages as a percentage of our revenue, which actually declined year over year, we have seen wage inflation.

But we have been able to cover that wage inflation with strong volume and with rate increases that we're seeing from our payers. So the labor cost.

In total have been manageable and have allowed us to continue to see volume growth.

Great. Thanks.

Our next question comes from Andrew Mok with UBS. Please go ahead.

Hi, Good morning wanted to follow up on those strong pricing trends when we think about the strong commercial price increases that you cited can you give us a bit more color on the drivers of that demand are there specific types of employers or payers that are driving that increase and any service lines that you would call out.

That drive a differentiated behavioral offering that resonates about commercial base. Thanks.

Yeah, Andrew we would say as we look at our different service lines that we have seen strong reimbursement increases this quarter across those service lines.

Of course, the timing of rate increases and the process that we go through with our payers can look different from one payer category to another.

With our commercial payers.

Talking to them.

In advance of an annual rate increase and we do stay focused at the local level and corporate level on on receiving those annual rate increases and as we do that we are talking to them about the value that we bring the programs that we design.

For their members and the investments that we make in the cost increases that we've seen in the services, we provide and so commercial has been.

And we're over 90% in network across our commercial payers, where we have long standing collaborative relationships and commercial has has been a source of good rate increases.

Our view is that it may take longer across all of our Medicaid and certainly Medicare.

To receive appropriate rate increases.

We've certainly seen a good environment for Medicaid in general.

But the process can look different from one state to another and then and then Medicare tends to be a very much a lagged.

Increase in terms of using cost data that several years.

Fire and setting each rate increase but it's been a stable.

Consistent payer and Theres another proposed rate increase this October .

In line and actually slightly better than what we've received historically, so broadly across our service lines and across our <unk>.

Different types of payers.

We're seeing positive rate increase trends.

Great and just as a follow up can you remind us how the CTC business impact the patient day revenue and volume metrics does that all flow through the revenue per patient day and is there a corresponding volume capture that.

Yes, a good question Andrew It does all flow through our revenue per day metric because that service line does not have patient days included in that metric.

So usually.

We are talking about.

The growth rate for our CTC business in total and to the extent that it's different from our same facility total revenue growth then it would impact our revenue per day metric.

For this particular quarter and in general looking back at the last several years. The CTC growth that we are seeing is in line with the overall same facility revenue growth and so it has not had a significant either positive or negative impact on our revenue per day, but that.

Is how it in some quarters could have an impact.

But any CTC related either volume or or per visit.

Trends have not had an impact on our revenue per day, this particular quarter.

Great. Thanks for the color.

Thanks.

Our next question comes from Peter Chickering with Deutsche Bank. Please go ahead.

Hey, good morning, guys. Thanks for taking my questions Chris Good to meet you sort of view the telephone you talked about revenue opportunities and Digitization, we've seen demand for telemedicine behavioral continue to grow is that an area that you think dedicated can be successfully.

Thanks, Peter I think it's a good question.

I think the company today is already using telehealth.

Quite successfully and is done sort of throughout the pandemic, particularly with our outpatient programs and individual and group counseling sessions.

Also have used it successfully when we need positions for our market and we're able to use it as an alternative to.

Locum coverage that said I think that there will continue to be opportunity just as the world continues to evolve into virtual offerings and while we don't think it will ultimately be a replacement.

For our inpatient care I think there will be opportunity for us to continue to look at innovation and to potentially even think through whether it makes sense to partner in certain instances as well, but any opportunity to leverage technology for the benefit of improving our health outcomes is something.

We would take a look at.

Alright, and then final question David on the CDC question again, what percent of revenues in the first quarter of 'twenty, one first quarter 'twenty two came from CDC.

I think it was around 15 or 16% for the for the first quarter.

Okay. So just mathematically, yes, it's about $130 Sir.

Yes growth to revenue per patient day come from CDC.

So relative to if you don't FTC involved.

Yes, that's right it's about that it's about 100 million for the quarter.

Got it Okay and then on the cost side is CVC serve more a more profitable segment kind of as that grows even in light of the overall revenue growth I guess can you sort of quantify sort of what type of margin tailwind that gives you to offset sort of the overall macro.

Inflationary pressures and also on the cost side the CDC more of a 60 40 labor versus suppliers. Just standard 90, 10-Q, just to understand more on the cost side.

Well the CTC margin that we see overall is similar to our same facility business of course, we are making investments in new CTC facilities and they don't go through the exact process that an inpatient facility goes through in terms of.

The ramp up in the licensing but.

But they do do go through a period of time, where they ramp up their operations and build their census, and other aspects of their business and so we've we've made investments in that in that.

It does on the inpatient side effects the margin that we see for that service line, but for the mature CTC facilities it depends on the market.

That's true across our company and across our service lines that one market to another our margin can be different.

The CTC business.

Just like our other businesses is seeing.

Strong volume growth reimbursement growth and is managing their cost.

And we're seeing strong margins there, but we're also seeing that in our other service lines. We don't we don't kind of manage the business to say that.

<unk> margins on one side will help us offset cost that we are.

Seeing grow in another service line, we are focused on each of our service lines, capturing the demand and the volume opportunities that they have and managing their cost.

I think you also asked about the CTC Mitch.

Mix and the operating expenses that we have it is labor intensive just like our other service lines.

The the majority of the costs that we see on the CTC side is similar in general General, we'd say that 70% of our operating cost is staffing or.

Our staffing related.

And that looks the same on the CTC side as it does on the inpatient side.

Okay, just to clarify on a mature CFC facility for as they mature keep facility does have the same margins.

Well not every facility has the same margin within any of our service lines.

So it can look different but when we talk about averages for our service line in total yes, we see similar margins across our service lines.

Great. Thanks, so much guys. Thanks.

Thanks Peter.

Our next question comes from John Ransom with Raymond James. Please go ahead.

Hey, good morning.

One for Chris.

I guess the impression of Acadia.

You know relative to say other providers.

Kind of a paper based medical records and don't track outcomes data.

Once patients are discharged from your parts at the payer level.

Do you think this is something that will change over the past.

The next couple of years and is it something that you might be a focus for you.

Yes, no. Thank you for the question John I think it is a good one.

I think it's something that has to change over time I mean at the end of the day, having come from having worked in numerous payers payers want quality care.

And they clearly are looking for superior outcomes and I think that's why we've been able to see the rate increases that David was talking about earlier.

I think they also are looking for solutions that are going to enable.

Patients to be identified even earlier.

Further upstream and I think that's going to continue to require technology and advanced analytics to make that happen. So I mean, obviously, the behavioral health sector as you well know missed out on some of the meaningful use investment years ago.

But there is legislation out there right now that would provide funding for the for the sector to effectively catch up.

Yeah.

Investment in EHR, which are overdue and I do think that that's something that will create a significant amount of value in the system I think that payers will continue to want to contract with the providers that are that are showcasing the best outcomes.

And that's something that we're going to continue to be very focused on in the days ahead.

Great and my.

My follow up would be as you know the company has cycled through a few M&A.

And the external growth, especially relative to your peers is very impressive, but I guess, if I were to say that.

If anything it's been missing.

We don't see a lot of what I'd call kind of small bore an M&A of existing.

Facilities.

Do you see opportunity in M&A to widen the aperture beyond what the company has already done and would you agree that maybe an area of opportunity.

Yes.

I would John I would say that I do think it's an area of opportunity.

I have not had an opportunity to do.

A thorough review of our entire pipeline.

Two clearly spend more time.

With our team on that front, but I've been very impressed with the work that they have done to date I think our pipeline since David Keys has come in is much more robust and we are.

Very proactive.

And being out there and looking for opportunities that meet our criteria around our disciplined capital allocation framework and so we'll continue to do that in.

I will need a little bit more time, but that's something that I'll certainly keep you updated on as we go.

Sure. Thanks, so much.

Our next question comes from Matthew Borsch with BMO capital markets. Please go ahead.

Good morning, Thanks for taking my question you actually have been Rossi filling in for Matt here.

Regarding patient acuity and the uptick in late stage compared to previous years, you reported an increase year over year and average length of stay just curious if that is a reflection of the type of acuity case. So what you saw this quarter and how you anticipate the cadence looks for the remainder of the year.

And then do you see length of stay continuing to increase as the year goes on.

Okay.

Yes, Ben.

We would attribute to.

The increased length of stay to a couple of factors for the first quarter. We have one the impact of the <unk> variant in January did have an impact on that metric.

In January we did see a greater impact on our acute service line and even our specialty service on where our longer length of stay services Rtc's stayed a little more consistent and stable.

The impact of that is that there was a disproportionate impact on admissions relative to patient days, which impacted that length of stay metric, but <unk>.

Separate from that we are seeing a longer length of stay within a couple of our service lines and it's still within the range that we expect but what we've seen is that our service mix within a service line can depend on the programs that we have the.

And age of our patients and you mentioned acuity, even the acuity of our patients and so we have seen some of our services that have a.

Different type of program and a more specialized program and the demographics and higher acuity, we have seen a greater mix in some of those programs and programs that have been added.

Net debt or to treat certain patients that need a longer length of stay.

So the service mix within our service lines have.

Part of that increase in the length of stay in terms of what it will look like for the rest of the year.

We may continue to see some of those trends certainly don't think the impact of the omicron variant.

While there is still COVID-19 out there in certain markets don't think that thats going to have the impact. It did in January but we may still see service mix.

Have an impact on our length of stay in the remainder of the year.

Great and then just as a follow up your guidance on the sixth CPUC. It is actually in the lower end of the initial guidance of 6% from last quarter's release.

Curious if that's just due to higher standard cost or maybe reflective of other conditions such as labor.

No we actually we may still be at the higher end of that range. We've talked about in this morning's comments at least six ctc's. So we still have a strong pipeline of new CTC locations. We just are talking about it as at least six and.

And we'll continue to keep everyone updated on what that looks like for the year, but continue to have a strong pipeline for new <unk>.

Okay, great. Thanks for that clarification.

<unk>.

Our next question comes from Sarah James with Barclays. Please go ahead.

Thank you.

So one of the divergences. Please notice coming out this quarter is on the LPN versus RN mix.

Due to staffing availability.

Some companies are shifting that mix from where their goal would be and I'm wondering what that looks like for you guys are doing.

Hey, Jay.

Being more intense than in either of those categories.

Is it changing how you see the progression to.

Moving labor to work at the highest end of their license.

Yes, we have had initiatives in place for several quarters now focused on the mix and where we can leverage different types of employees to do certain tasks and I know.

Our operations team has been focused on leading our rins and other clinical employees focus on providing patient care and taking away as much as possible in a clerical duties as they may have.

So looking at our model for staffing has been part of our initiative.

In terms of availability of one type of nurse from another it can depend on the market.

But we have different service lines, where we have a different nursing mix within each service line acute is where we see a higher percentage of our ends and where we're focused on potentially leveraging different types of nurses within our acute facilities, but we already have a higher LPN Mitch.

As we think about our other service lines RTC specialty and CTC as I mentioned earlier has a very high percentage of Lpns.

And so I know recruiting and retention is a focus across all job categories in.

And it can depend on the market, but we already have a mix and we've already had initiatives in place to to.

To really look at letting each job category focus on on their skill set and be able to work in their skill set within our facilities.

Great. Thank you.

Yeah.

Thank you, Sir and with that this concludes our question answer session I would like to turn the conference back over to the Chief Executive Officer, Christopher Hunter for any closing remarks.

Thank you so before we end the call I do want to acknowledge the Kt is committed facility leaders clinicians and over 22000 dedicated employees across the country, who just continued to provide quality patient care for those seeking treatment for mental health and substance use issues I really look forward to meeting with more.

Our employees into visiting additional facilities in the coming months our employees truly are the backbone of this organization and their strength is one of the main reasons that I joined Acadia.

With a strong first quarter performance, we have an opportunity to now build on our momentum we are well positioned to meet the growing demand for our services with a proven operating model an expansive network of 238 facilities and diversified service lines across the continuum of care.

Look forward to working with the <unk> management team and board as we pursue a strategic direction that continues to provide positive outcomes for the patients under our care and deliver greater value for all of our stakeholders.

Thank you for being with US this morning and for your interest in Acadia as a public company. It is vitally important that I get to know our investors and I look forward to the opportunities ahead to speak and meet in person. If you have additional questions. Today, please do not hesitate to contact us directly.

Thank you and have a good day everyone.

The conference has now concluded. Thank you for attending today's presentation you may now disconnect.

Q1 2022 Acadia Healthcare Company Inc Earnings Call

Demo

Acadia Healthcare Company

Earnings

Q1 2022 Acadia Healthcare Company Inc Earnings Call

ACHC

Wednesday, May 4th, 2022 at 1:00 PM

Transcript

No Transcript Available

No transcript data is available for this event yet. Transcripts typically become available shortly after an earnings call ends.

Want AI-powered analysis? Try AllMind AI →